To the best of our knowledge, limited studies were performed on BRCA immunoexpression and hormone receptor status in our locality, henceforth, this research was performed to check BRCA1 immunoexpression and its association with ER, PR and Her2/neu immunoexpression in infiltrative ductal carcinoma of the breast. This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.